Abstract:Diabetes is a common comorbidity in the U.S. and is associated with adverse outcomes in a variety of disease processes. Other cancer specialties have shown an association of diabetes with poor oncologic outcomes. We hypothesized that pathologic complete response (pCR) would be less likely among diabetic patients with esophageal cancer who underwent neoadjuvant chemoradiation therapy followed by esophagectomy resulting in worse overall survival (OS). We performed a retrospective chart review at 2 high-volume academic hospitals of all patients with esophageal cancer who received neoadjuvant chemoradiation therapy followed by esophagectomy from 2010-2019. Patients were excluded if they had histology other than squamous cell carcinoma or adenocarcinoma, did not receive multi-agent chemotherapy or received a radiation dose <39.6 Gy. The primary outcome of interest was pCR and secondary outcome was OS. Multivariable logistic regression was used to assess the likelihood of pCR and Cox hazard analysis was used to assess OS. In total, 244 patients met inclusion criteria: 190 (77.9%) were non-diabetic and 54 (22.1%) were diabetic. Diabetic and non-diabetic patients were similar in age, sex, institution where they received treatment, ASA class, comorbidities, histologic sub-type, clinical T and N stage, chemotherapy regimen and radiation dose. Diabetic patients were more likely to have a higher body mass index (29.1 vs 25.9, p < 0.001) and hypertension (87.0% vs 47.9%, p < 0.001). On univariable analysis, diabetes was the only factor associated with decreased likelihood of pCR (p = 0.04). Multivariable analysis showed diabetes was again the only factor associated with a decreased likelihood of pCR (OR 0.32, p = 0.03). Cox survival analysis showed that older age (HR 1.03, p = 0.02) and overall posttreatment pathologic stage 2 (HR 2.16, p = 0.03), stage 3 (HR 3.25, p < 0.001), and stage 4 (HR 5.75, p < 0.001) compared to pCR were associated with worse OS, however diabetes alone had no effect (HR 1.01, p = 0.98). This multi-institutional study shows that diabetes adversely affects pCR in patients receiving neoadjuvant treatment for esophageal cancer. Almost a quarter of patients with esophageal cancer have diabetes suggesting implications for management of these patients. Future studies are warranted to determine the optimal neoadjuvant treatment strategy for esophageal cancer patients with diabetes.

Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta‐analysis

Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: the impact of pre-existing diabetes mellitus.

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis

The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Diabetes Mellitus And Poorer Prognosis In Hepatocellular Carcinoma: A Systematic Review And Meta-Analysis

Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis

[Impact of Diabetes Mellitus on Clinicopathological Factors and Prognosis of Patients with Colorectal Cancer.].

A Retrospective-Analysis of the Correlation Between Diabetes Mellitus and Cancer

Diabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients

[Diabetes mellitus as a prognostic marker in oropharyngeal and laryngeal squamous cell carcinoma]

Diabetes and its Potential Impact on Head and Neck Oncogenesis

Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis

Nutritional status and survival of 8247 cancer patients with or without diabetes mellitus—results from a prospective cohort study

Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

The Effect of Diabetes on Pathologic Complete Response Among Patients With Esophageal Cancer

Effect of Metformin on the Prognosis of Chemoradiotherapy Cancer Patients: a Systematic Review and Meta-Analysis of Randomized Controlled Trials and Cohort Studies

Mortality and glycemic control among patients with gastric and esophageal cancer and diabetes mellitus.

Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies.

Impact Of Diabetes Mellitus On The Prognosis Of Patients With Hepatocellular Carcinoma After Curative Hepatectomy

Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients